Surgical stabilization of rib fracture patients versus nonoperative controls treated by a multidisciplinary team in a single institution

被引:1
|
作者
Bauer, Frank [1 ]
Haag, Susan [1 ]
Najafi, Kaveh [1 ]
Miller, Brian [1 ]
Kepros, John [1 ]
机构
[1] HonorHlth Scottsdale Osborn Med Ctr, Surg & Crit Care, Scottsdale, AZ 85251 USA
关键词
Rib fixation; Rib fracture; Surgical stabilization of rib fracture; Multidisciplinary care; FLAIL CHEST INJURIES; MANAGEMENT; FIXATION; METAANALYSIS;
D O I
10.1016/j.heliyon.2023.e15205
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Despite promising evidence, surgical stabilization of rib fractures (SSRF) is not ubiquitously offered in all trauma centers. Some centers struggle with patient selection while some struggle due to surgeon comfort with the technique. To address this issue, our trauma center developed a multidisciplinary SSRF approach between orthopedic and trauma surgery.Methods: This retrospective study compared 43 patients who underwent SSRF at a level 1 trauma center with 43 nonoperatively managed controls. Our study Indications were flail chest with >3 segments; non-flail with severe, bi-cortical displacement of >3 contiguous segments. Main outcome measures included mortality, ICU duration, hospital stay LOS, rates of ventilator -associated pneumonia (VAP) and ventilator days.Results: Results of SSRF included decreases in mortality (2% vs 16.3%; p = 0.03) and in ICU duration. Patients with SSRF had a significantly shorter duration in the ICU than the nonoperative group (8.72 vs 14 days; p = 0.013) but a similar hospital duration (LOS mean, 12.81 vs 15.2; p = 0.29). Less patients in the SSRF group developed VAP but the difference was not significant (2% vs 14%, p 1/4 0.055). Discussion: SSRF patient outcomes supported prior evidence. The tandem approach had benefits as surgeons were able to leverage skills and expertise, increase collaboration between services, and complete more difficult reconstructions. Our experience may serve as a model for trauma centers interested in starting a new program or enhancing current service offerings.
引用
收藏
页数:6
相关论文
共 25 条
  • [21] Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal Tumors: 25-Year Experience in a Single Institution
    Park, Se -Jun
    Park, Jin-Sung
    Lee, Chong-Suh
    Kang, Byeong-Jik
    Jung, Choong-Won
    CLINICS IN ORTHOPEDIC SURGERY, 2023, 15 (01) : 109 - 117
  • [22] In response to: A multicenter, prospective, controlled clinical trial of surgical stabilization of rib fractures in patients with severe, NONFLAIL fracture patterns (Chest Wall Injury Society NONFLAIL) Response
    Pieracci, Fredric M.
    Leasia, Kiara
    Bauman, Zach
    Eriksson, Evert A.
    Lottenberg, Lawrence
    Majercik, Sarah
    Powell, Ledford
    Sarani, Babak
    Semon, Gregory
    Thomas, Bradley
    Zhao, Frank
    Dyke, Cornelius
    Doben, Andrew R.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2020, 89 (04) : E123 - E124
  • [23] Negative Pressure Wound Therapy Can Prevent Surgical Site Infections Following Sternal and Rib Fixation in Trauma Patients: Experience From a Single-Institution Cohort Study
    Lodin, Daud
    Florio, Taylor
    Genuit, Thomas
    Hus, Nir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [24] Factors affecting long-term outcome of patients treated for malignant colorectal polyps: endoscopic versus surgical treatment. A single center experience
    Ugenti, Ippazio
    Martines, Gennaro
    Andriola, Valeria
    De Marinis, Emma C.
    Iambrenghi, Onofrio Caputi
    CHIRURGIA-ITALY, 2019, 32 (04): : 166 - 171
  • [25] Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution
    Armas, Sebastian
    Huertas-Ayala, Carolina
    Chan, Randall Y.
    Chi, Yueh-Yun
    Huh, Winston W.
    Termuhlen, Amanda
    Gaynon, Paul S.
    Kovach, Alexandra E.
    Doan, Andrew
    PEDIATRIC BLOOD & CANCER, 2022, 69 (05)